A pitvarfibrilláció és a krónikus szívelégtelenség a kardiológiai betegségek két nagy csoportját alkotják, amelyek gyakran együtt jelentkeznek. A kardiális reszinkronizációs terápia egy fontos, nem gyógyszeres, eszközös terápiás lehetőség előrehaladott szívelégtelenségben, amelynek morbiditás- és mortalitáscsökkentő hatását nagy randomizált vizsgálatok igazolták. A legutóbbi európai és amerikai ajánlás javasolja bizonyos esetekben a reszinkronizációs kezelést pitvarfibrilláló szívelégtelen betegekben. A jelen összefoglaló az aktuális irodalmi áttekintés alapján elemzi a pitvarfibrilláció és krónikus szívelégtelenség együttesét, a reszinkronizációs terápia hatását pitvarfibrilláció esetén, valamint a terápiás lehetőségeket ritmuskontroll vagy frekvenciakontroll tekintetében. A szerzők részletezik, hogyan befolyásolja a pitvarfibrilláció a biventricularis ingerlést, hogyan mérsékelhető a pitvari tachyarrhythmia negatív hatása, miközben a problémakörről egy átfogó képet alkotnak. Orv. Hetil., 2011, 152, 1757–1763.
Fuster, V., Rydén, L. E., Asinger, R. W. és mtsai: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur. Heart J., 2001, 22, 1852–1923. (Circulation, 2001, 104, 2118–2150.; J. Am. Coll. Cardiol., 2001, 22, 1852–1923.)
Asinger R. W. , 'ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation ' (2001 ) 22 Eur. Heart J. : 1852 -1923 .
Mosterd, A., Hoes, A. W., de Bruyne, M. C. és mtsai: Prevalence of hearth failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur. Heart J., 1999, 20, 447–455.
Bruyne M. C. , 'Prevalence of hearth failure and left ventricular dysfunction in the general population; The Rotterdam Study ' (1999 ) 20 Eur. Heart J. : 447 -455 .
Ho, K. K., Pinsky, J. L., Kannel, W. B. és mtsa: The epidemiology of the heart failure: the Framingham Study. J. Am. Coll. Cardiol., 1993, 22 (Suppl. 4), 6A–13A.
Kannel W. B. , 'The epidemiology of the heart failure: the Framingham Study ' (1993 ) 22 J. Am. Coll. Cardiol. : 6A -13A .
Maisel, T. S. M., Stevenson, L. W.: Atrial fibrillation in heart failure: epidemiology, pathophysiology and rationale for therapy. Am. J. Cardiol., 2003, 91, 2D–8D.
Stevenson L. W. , 'Atrial fibrillation in heart failure: epidemiology, pathophysiology and rationale for therapy ' (2003 ) 91 Am. J. Cardiol. : 2D -8D .
Tsang, T. S., Gersh, B. J., Appleton, C. P. és mtsai: Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J. Am. Coll. Cardiol., 2002, 40, 1636–1644.
Appleton C. P. , 'Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women ' (2002 ) 40 J. Am. Coll. Cardiol. : 1636 -1644 .
Gottdiener, J. S., Kitzman, D. W., Aurigemma, G. P. és mtsai: Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons > or = 65 years of age (the cardiovascular health study). Am. J. Cardiol., 2006, 97, 83–89.
Aurigemma G. P. , 'Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons > or = 65 years of age (the cardiovascular health study) ' (2006 ) 97 Am. J. Cardiol. : 83 -89 .
Li, D., Fareh, S., Leung, T. K. és mtsa: Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation, 1999, 100, 87–95.
Leung T. K. , 'Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort ' (1999 ) 100 Circulation : 87 -95 .
Everett, T. H., Verheule, S., Wilson, E. E. és mtsai: Left atrial dilatation resulting from chronic mitral regurgitation decreases spatiotemporal organization of atrial fibrillation in left atrium. Am. J. Physiol. Heart Circ. Physiol., 2004, 286, H2452–H2460.
Wilson E. E. , 'Left atrial dilatation resulting from chronic mitral regurgitation decreases spatiotemporal organization of atrial fibrillation in left atrium ' (2004 ) 286 Am. J. Physiol. Heart Circ. Physiol. : H2452 -H2460 .
Neuberger, H. R., Schotten, U., Blaauw, Y. és mtsai: Chronic atrial dilation, electrical remodeling and atrial fibrillation in the goat. J. Am. Coll. Cardiol., 2006, 47, 644–653.
Blaauw Y. , 'Chronic atrial dilation, electrical remodeling and atrial fibrillation in the goat ' (2006 ) 47 J. Am. Coll. Cardiol. : 644 -653 .
Sanders, P., Morton, J. B., Davidson, N. C. és mtsa: Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation, 2003, 108, 1461–1468.
Davidson N. C. , 'Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans ' (2003 ) 108 Circulation : 1461 -1468 .
Van den Berg, M. P., Van Veldhuisen, D. J., Crijns, H. J. és mtsa: Reversion of tachycardiomyopathy after beta-blocker. Lancet, 1993, 341, 1667.
Crijns H. J. , 'Reversion of tachycardiomyopathy after beta-blocker ' (1993 ) 341 Lancet : 1667 -.
Schoonderwoerd, B. A., Van Gelder, I. C., Van Veldhuisen, D. J. és mtsai: Electrical remodeling and atrial dilation during atrial tachycardia are influenced by ventricular rate: role of developing tachycardiomyopathy. J. Cardiovasc. Electrophysiol., 2001, 12, 1404–1410.
Veldhuisen D. J. , 'Electrical remodeling and atrial dilation during atrial tachycardia are influenced by ventricular rate: role of developing tachycardiomyopathy ' (2001 ) 12 J. Cardiovasc. Electrophysiol. : 1404 -1410 .
Krahn, A. D., Manfreda, J., Tate, R. B. és mtsa: The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up study. Am. J. Med., 1995, 98, 476–484.
Tate R. B. , 'The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up study ' (1995 ) 98 Am. J. Med. : 476 -484 .
Schotten, U., Ausma, J., Stellbrink, C. és mtsai: Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation, 2001, 103, 691–698.
Stellbrink C. , 'Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation ' (2001 ) 103 Circulation : 691 -698 .
Cha, Y. M., Redfield, M. M., Shen, W. K. és mtsa: Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation, 2004, 109, 2839–2843.
Shen W. K. , 'Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle ' (2004 ) 109 Circulation : 2839 -2843 .
Wang, T. J., Larson, M. G., Levy, D. és mtsai: Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation, 2003, 107, 2920–2925.
Levy D. , 'Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study ' (2003 ) 107 Circulation : 2920 -2925 .
Cleland, J. G. F., Daubert, J. C., Erdmann, E. és mtsai: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med., 2005, 352, 1539–1549.
Erdmann E. , 'The effect of cardiac resynchronization on morbidity and mortality in heart failure ' (2005 ) 352 N. Engl. J. Med. : 1539 -1549 .
Swedberg, K., Cleland, J., Dargie, H. és mtsai: Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur. Heart J., 2005, 26, 1115–1140.
Dargie H. , 'Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology ' (2005 ) 26 Eur. Heart J. : 1115 -1140 .
Vardas, P. E., Auricchio, A., Blanc, J. J. és mtsai: Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur. Heart J., 2007, 28, 2256–2295.
Blanc J. J. , 'Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association ' (2007 ) 28 Eur. Heart J. : 2256 -2295 .
Upadhyay, G. A., Choudhry, N. K., Auricchio, A. és mtsai: Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J. Am. Coll. Cardiol., 2008, 52, 1239–1246.
Auricchio A. , 'Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies ' (2008 ) 52 J. Am. Coll. Cardiol. : 1239 -1246 .
Gasparini, M., Regoli, F., Galimberti, P. és mtsai: Cardiac resynchronization therapy in heart failure patients with atrial fibrillation. Europace, 2009, 11 (Suppl. 5), V82–V86.
Galimberti P. , 'Cardiac resynchronization therapy in heart failure patients with atrial fibrillation ' (2009 ) 11 Europace : V82 -V86 .
Epstein, A. E, DiMarco, J. P., Ellenbogen, K. A. és mtsai: ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation, 2008, 117, e350–e408.
Ellenbogen K. A. , 'ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons ' (2008 ) 117 Circulation : e350 -e408 .
Caldwell, J. C., Contractor, H., Petkar, S. és mtsai: Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy. Europace, 2009, 11, 1295–1300.
Petkar S. , 'Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy ' (2009 ) 11 Europace : 1295 -1300 .
Kamath, G. S., Cotiga, D., Koneru, J. N. és mtsai: The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy. J. Am. Coll. Cardiol., 2009, 53, 1050–1055.
Koneru J. N. , 'The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy ' (2009 ) 53 J. Am. Coll. Cardiol. : 1050 -1055 .
Talajic, M., Khairy, P., Levesque, S. és mtsai: Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. J. Am. Coll. Cardiol., 2010, 55, 1796–1802.
Levesque S. , 'Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation ' (2010 ) 55 J. Am. Coll. Cardiol. : 1796 -1802 .
Hügl, B., Bruns, H. J., Unterberg-Buchwald, C. és mtsai: Atrial fibrillation burden during the post-implant period after CRT using device-based diagnostics. J. Cardiovasc. Electrophysiol., 2006, 17, 813–817.
Unterberg-Buchwald C. , 'Atrial fibrillation burden during the post-implant period after CRT using device-based diagnostics ' (2006 ) 17 J. Cardiovasc. Electrophysiol. : 813 -817 .
Gasparini, M., Steinberg, J. S., Arshad, A. és mtsai: Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study. Eur. Heart J., 2010, 31, 976–983.
Arshad A. , 'Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study ' (2010 ) 31 Eur. Heart J. : 976 -983 .
Khan, M. N., Jaïs, P., Cummings, J. és mtsai: Pulmonary-Vein isolation for atrial fibrillation in patients with heart failure. N. Engl. J. Med., 2008, 359, 1778–1785.
Cummings J. , 'Pulmonary-Vein isolation for atrial fibrillation in patients with heart failure ' (2008 ) 359 N. Engl. J. Med. : 1778 -1785 .
Lavalle, C., Ricci, R. P., Santini, M.: Atrial tachyarrhythmias and cardiac resynchronisation therapy: clinical and therapeutic implications. Heart, 2010, 96, 1174–1178.
Santini M. , 'Atrial tachyarrhythmias and cardiac resynchronisation therapy: clinical and therapeutic implications ' (2010 ) 96 Heart : 1174 -1178 .
Ueng, K. C., Tsai, T. P., Tsai, C. F. és mtsai: Acute and long-term effects of atrioventricular junction ablation and VVIR pacemaker in symptomatic patients with chronic lone atrial fibrillation and normal ventricular response. J. Cardiovasc. Electrophysiol., 2001, 12, 303–309.
Tsai C. F. , 'Acute and long-term effects of atrioventricular junction ablation and VVIR pacemaker in symptomatic patients with chronic lone atrial fibrillation and normal ventricular response ' (2001 ) 12 J. Cardiovasc. Electrophysiol. : 303 -309 .
Bardy, G. H., Lee, K. L., Mark, D. B. és mtsai: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med., 2005, 352, 225–237.
Mark D. B. , 'Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure ' (2005 ) 352 N. Engl. J. Med. : 225 -237 .
The Digitalis Investigation Group: The effect of digoxin on mortality and morbidity in patients with heart failure. N. Engl. J. Med., 1997, 336, 525–533.
'The effect of digoxin on mortality and morbidity in patients with heart failure ' (1997 ) 336 N. Engl. J. Med. : 525 -533 .
Schrickel, J. W., Schwab, J. O., Yang, A. és mtsai: Pro-arrhythmic effects of amiodarone and concomitant rate-control medication. Europace, 2006, 8, 403–407.
Yang A. , 'Pro-arrhythmic effects of amiodarone and concomitant rate-control medication ' (2006 ) 8 Europace : 403 -407 .
Davy, J., Herold, M., Hoglund, C. és mtsai: Dronedarone or the control of ventricular rate is permanent atrial fibrillation: the efficacy and safety of dronedarone for the control of ventricular rate during atrial fibrillation (ERATO) study. Am. Heart J., 2008, 156, 527e1–527e9.
Hoglund C. , 'Dronedarone or the control of ventricular rate is permanent atrial fibrillation: the efficacy and safety of dronedarone for the control of ventricular rate during atrial fibrillation (ERATO) study ' (2008 ) 156 Am. Heart J. : 527e1 -527e9 .
Kerr, A. J., Williams, M. J., Stewart, R. A.: Ventricular rate and beat-to-beat variation of stroke volume in atrial fibrillation. Am. J. Cardiol., 2001, 87, 1116–1119.
Stewart R. A. , 'Ventricular rate and beat-to-beat variation of stroke volume in atrial fibrillation ' (2001 ) 87 Am. J. Cardiol. : 1116 -1119 .
Ciaramitaro, C., Sgarito, G., Solimene, F. és mtsai: Role of rate control and regularization through pacing in patients with chronic atrial fibrillation and preserved ventricular function: the VRR study. Pacing Clin. Electrophysiol., 2006, 29, 866–874.
Solimene F. , 'Role of rate control and regularization through pacing in patients with chronic atrial fibrillation and preserved ventricular function: the VRR study ' (2006 ) 29 Pacing Clin. Electrophysiol. : 866 -874 .
Brignole, M., Menozzi, C., Gianfranchi, L. és mtsai: Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation, 1998, 98, 953–960.
Gianfranchi L. , 'Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study ' (1998 ) 98 Circulation : 953 -960 .
Natale, A., Zimerman, L., Tomassoni, G. és mtsai: AV node ablation and pacemaker implantation after withdrawal of effective rate-control medications for chronic atrial fibrillation: effect on quality of life and exercise performance. Pacing Clin. Electrophysiol., 1999, 22, 1634–1639.
Tomassoni G. , 'AV node ablation and pacemaker implantation after withdrawal of effective rate-control medications for chronic atrial fibrillation: effect on quality of life and exercise performance ' (1999 ) 22 Pacing Clin. Electrophysiol. : 1634 -1639 .
Ozcan, C. N., Jahangir, A., Friedman, P. A. és mtsai: Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. Engl. J. Med., 2001, 344, 1043–1051.
Friedman P. A. , 'Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation ' (2001 ) 344 Engl. J. Med. : 1043 -1051 .
Sweeney, M. O., Wathen, M. S., Volosin, K. és mtsai: Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation, 2005, 111, 2898–2905.
Volosin K. , 'Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial ' (2005 ) 111 Circulation : 2898 -2905 .
Szili-Török, T., Mihalcz, A., Jordaens, L.: The ‘Happy Ending Problem’ of cardiac pacing? Cardiac resynchronization therapy for patients with atrial fibrillation and heart failure after atrioventricular junction ablation. Europace, 2008, 10, 779–781.
Jordaens L. , 'The ‘Happy Ending Problem’ of cardiac pacing? Cardiac resynchronization therapy for patients with atrial fibrillation and heart failure after atrioventricular junction ablation ' (2008 ) 10 Europace : 779 -781 .
Koplan, B. A., Kaplan, A. J., Weiner, S. és mtsai: Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? J. Am. Coll. Cardiol., 2009, 53, 355–360.
Weiner S. , 'Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? ' (2009 ) 53 J. Am. Coll. Cardiol. : 355 -360 .
Wilton, S. B., Leung, A. A., Ghali, W. A. és mtsai: Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: A systematic review and meta-analysis. Heart Rhythm, 2011, 8, 1088–1094.
Ghali W. A. , 'Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: A systematic review and meta-analysis ' (2011 ) 8 Heart Rhythm : 1088 -1094 .
Leon, A. R., Greenberg, J. M., Kanuru, N. és mtsai: Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J. Am. Coll. Cardiol., 2002, 39, 1258–1263.
Kanuru N. , 'Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing ' (2002 ) 39 J. Am. Coll. Cardiol. : 1258 -1263 .
Molhoek, S. G., Bax, J. J., Bleeker, G. B. és mtsai: Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am. J. Cardiol., 2004, 94, 1506–1509.
Bleeker G. B. , 'Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation ' (2004 ) 94 Am. J. Cardiol. : 1506 -1509 .
Doshi, R. N., Daoud, E. G., Fellows, C. és mtsai: Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J. Cardiovasc. Electrophysiol., 2005, 16, 1160–1165.
Fellows C. , 'Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study) ' (2005 ) 16 J. Cardiovasc. Electrophysiol. : 1160 -1165 .
Brignole, M., Gammage, M., Puggioni, E. és mtsai: Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation. Eur. Heart J., 2005, 26, 712–722.
Puggioni E. , 'Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation ' (2005 ) 26 Eur. Heart J. : 712 -722 .
Gasparini, M., Auricchio, A., Metra, M. és mtsai: Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur. Heart J., 2008, 29, 1644–1652.
Metra M. , 'Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation ' (2008 ) 29 Eur. Heart J. : 1644 -1652 .
Ferreira, A. M., Adragão, P., Cavaco, D. M. és mtsai: Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation. Europace, 2008, 10, 809–815.
Cavaco D. M. , 'Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation ' (2008 ) 10 Europace : 809 -815 .
Schütte, F., Lüdorff, G., Grove, R. és mtsai: Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation. Cardiol. J., 2009, 16, 246–249.
Grove R. , 'Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation ' (2009 ) 16 Cardiol. J. : 246 -249 .